Cite
HARVARD Citation
Gulliver, W. et al. (2021). Real‐world effectiveness of adalimumab in patients with moderate‐to‐severe hidradenitis suppurativa: the 1‐year SOLACE study. Journal of the European Academy of Dermatology and Venereology. pp. 2431-2439. [Online].